DUBLIN, Jan. 13, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that a new presentation related to Dupuytren's contracture (DC) and XIAFLEX® (collagenase clostridium histolyticum, or ...
DUBLIN, Jan. 21, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that it reached a milestone: 100,000 patients with Peyronie's disease (PD) have been prescribed XIAFLEX® (collagenase ...
MIAMI -- Men receiving collagenase clostridium histolyticum (CCH; Xiaflex) injections for Peyronie's disease had similar levels of overall satisfaction to surgery, and with fewer adverse effects, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results